T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab von Bughani, Usha, Saha, Arindam, Kuriakose, Anshu, Nair, Reshmi, Sadashivarao, Ravindra B, Venkataraman, Rasika, Patel, Swati, Deshchougule, Anuja Tushar, S, Satish Kumar, Montero, Enrique, Pai, Harish V, Palanivelu, Dinesh V, Melarkode, Ramakrishnan, Nair, Pradip

Volltext

Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab von Bughani, Usha, Saha, Arindam, Kuriakose, Anshu, Nair, Reshmi, Sadashivarao, Ravindra B, Venkataraman, Rasika, Patel, Swati, Tushar Deshchougule, Anuja, Satish, Kumar S, Montero, Enrique, Pai, Harish V, Palanivelu, Dinesh V, Melarkode, Ramakrishnan, Nair, Pradip

Volltext

874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy von Boreddy, Srinivas Reddy, Nair, Reshmi, Banerjee, Arindam, Kuriakose, Anshu, Pandey, Prashant Kumar, Dey, Chaitali, Shri, Meena, Rao, Shruthi, Shivakumar, Bhadravathi Marigowda, Kuriakose, Moni Abhram, Reddy, Ram Bhupal, Suresh, Amritha, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip

Volltext

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the ApcMin/+ mouse model von Li, Shiwang, Ghaleb, Amr M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.

Volltext

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth von Boreddy, Srinivas Reddy, Nair, Reshmi, Pandey, Prashant Kumar, Kuriakose, Anshu, Marigowda, Shivakumar Bhadravathi, Dey, Chaitali, Banerjee, Arindam, Kulkarni, Hanumant, Sagar, Milind, Krishn, Shiv Ram, Rao, Shruthi, Ar, Madhukara, Tiwari, Vinita, Alke, Bhavna, Mv, Prashantha Kumar, Shri, Meena, Dhamne, Chaitrali, Patel, Sonal, Sharma, Pinky, Periyasamy, Sankar, Bhatnagar, Jaya, Kuriakose, Moni Abraham, Reddy, Ram Bhupal, Suresh, Amritha, Sreenivas, Suma, Govindappa, Nagaraja, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip

Volltext

MK2: a novel molecular target for anti-inflammatory therapy von Duraisamy, Senthil, Bajpai, Malini, Bughani, Usha, Dastidar, Sunanda G, Ray, Abhijit, Chopra, Puneet

Volltext

Abstract 6339: BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition von Boreddy, Srinivas Reddy, Nair, Reshmi, Pandey, Prashant Kumar, Kuriakose, Anshu, Banerjee, Arindam, Dey, Chaitali, R, Madhukara A, Shivakumar, Bhadravathi Marigowda, Kulkarni, Hanumant, Sagar, Milind, V, Prashantha Kumar M., Krishn, Shiv Ram, Bhatnagar, Jaya, Kuriakose, Moni Abhram, Reddy, Ram Bhupal, Suresh, Amritha, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip, Salazar, Rachel

Volltext

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model von Li, Shiwang, Ghaleb, Amr M, He, Jing, Bughani, Usha, Bialkowska, Agnieszka B, Yang, Vincent W, Joshi, Harish C

Volltext

Chemoprevention of familial adenomatous polyposis by bromo‐noscapine (EM011) in the Apc Min/+ mouse model von Li, Shiwang, Ghaleb, Amr M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.

Volltext

Molecular targeting of E3 ligases - a therapeutic approach for cancer von Lakshmanan, Manikandan, Bughani, Usha, Duraisamy, Senthil, Diwan, Manish, Dastidar, Sunanda, Ray, Abhijit

Volltext

Abstract 939: Chemoprevention of familial adenomatous polyposis by EM011 in the ApcMin/+ mouse model von Li, Shiwang, Ghaleb, Amy M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.

Volltext

Use of itolizumab to reduce phosphorylation of CD6 von Saha, Arindam, Melarkode, Ramakrishnan, Nair, Pradip, Sadashivarao, Ravindra Belavinakodige, Bughani, Usha

Volltext bestellen

USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6 von SAHA, Arindam, MELARKODE, Ramakrishnan, NAIR, Pradip, SADASHIVARAO, Ravindra Belavinakodige, BUGHANI, Usha

Volltext bestellen

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins von Nair, Reshmi, Srinivasa, Sreesha P, Govindappa, Nagaraj, Bughani, Usha

Volltext bestellen

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON von MANIAN, BALA S, MONTERO CASIMIRO, JOSE ENRIQUE, NAIR, PRADIP, BARVE, ABHIJIT, MELARKODE, RAMAKRISHNAN, BUGHANI, USHA

Volltext bestellen

ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING AND REDUCING NEGATIVE EFFECTS OF A CORONAVIRUS INCLUDING COVID-19 von CROMBET RAMOS, Tania, RAMOS SUZARTE, Mayra, MAZUMDAR SHAW, Kiran, NAIR, Pradip, LEÓN MONZÓN, Kalet, RAMAKRISHNAN, Melarkode Subbaraman, CASIMIRO, Jose Enrique Montero, BUGHANI, Usha, ATHALYE, Sandeep Nilkanth

Volltext bestellen

ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING AND REDUCING NEGATIVE EFFECTS OF A CORONAVIRUS INCLUDING COVID-19 von CROMBET RAMOS, Tania, RAMOS SUZARTE, Mayra, MAZUMDAR SHAW, Kiran, NAIR, Pradip, LEÓN MONZÓN, Kalet, RAMAKRISHNAN, Melarkode Subbaraman, CASIMIRO, Jose Enrique Montero, BUGHANI, Usha, ATHALYE, Sandeep Nilkanth

Volltext bestellen

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON von MANIAN, BALA S, MONTERO CASIMIRO, JOSE ENRIQUE, NAIR, PRADIP, BARVE, ABHIJIT, MELARKODE, RAMAKRISHNAN, BUGHANI, USHA

Volltext bestellen

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON von MELARKODE, Ramakrishnan, NAIR, Pradip, MANIAN, Bala S, MONTERO CASIMIRO, José Enrique, BARVE, Abhijit, BUGHANI, Usha

Volltext bestellen

Use of a CD6 binding partner and method based thereon von Manian, Bala S, Barve, Abhijit, Melarkode, Ramakrishnan, Montero Casimiro, Jose Enrique, Nair, Pradip, Bughani, Usha

Volltext bestellen